These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3032812)

  • 1. Practical guidelines for the use of converting enzyme inhibitors in congestive heart failure.
    Dickstein K
    Int J Cardiol; 1987 Apr; 15(1):1-5. PubMed ID: 3032812
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
    Cohn JN; Levine TB
    Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.
    Faxon DP; Creager MA; Halperin JL; Gavras H; Coffman JD; Ryan TJ
    Circulation; 1980 May; 61(5):925-30. PubMed ID: 6153939
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
    Cody RJ; Covit AB; Schaer GL; Laragh JH
    J Am Coll Cardiol; 1983 Apr; 1(4):1154-9. PubMed ID: 6187789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
    Robertson JI
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S2-8. PubMed ID: 2422488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of patients with congestive heart failure. Potential role of converting enzyme inhibitors in improving survival.
    Pitt B
    Am J Med; 1986 Oct; 81(4C):32-5. PubMed ID: 2877579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of angiotensin converting enzyme inhibitors in hypertension.
    Gavras I; Gavras H
    Am J Med; 1986 Oct; 81(4C):28-31. PubMed ID: 3022582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 9. [The clinical use of angiotensin converting enzyme inhibitors].
    Fyhrquist F
    Duodecim; 1986; 102(22):1709-16. PubMed ID: 3026771
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
    Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension treatment 1985: significance of calcium antagonists and angiotensin-converting enzyme inhibitors].
    Weidmann P
    Ther Umsch; 1985 Aug; 42(8):528-39. PubMed ID: 2996166
    [No Abstract]   [Full Text] [Related]  

  • 12. Restoration of cardiac function and structure by converting enzyme inhibition possibilities and limitations of long-term treatment in hypertension and heart failure.
    Fouad FM; Tarazi RC
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S53-7. PubMed ID: 2422493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some advances in angiotensin converting enzyme inhibitors].
    Jia L
    Sheng Li Ke Xue Jin Zhan; 1985 Jul; 16(3):229-34. PubMed ID: 3003897
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure.
    Ikram H; Webster MW; Nicholls MG; Lewis GR; Richards AM; Crozier IG
    Aust N Z J Med; 1986 Feb; 16(1):61-3. PubMed ID: 3010929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
    Levine TB; Cohn JN
    Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension].
    Salvetti A; Pedrinelli R; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Cardiologia; 1984; 29(1-2):103-20. PubMed ID: 6085475
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug information. New principle in the treatment of elevated blood pressure].
    Dahlerup J
    Sygeplejersken; 1985 Jul; 85(27):16-7. PubMed ID: 3000014
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of hypertensive heart disease: vasodilator agents in the forefront].
    Bolli P; Bühler FR
    Ther Umsch; 1984 Feb; 41(2):150-5. PubMed ID: 6200947
    [No Abstract]   [Full Text] [Related]  

  • 19. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiotensin-converting enzyme inhibitor in heart failure].
    Dickstein K; Aarsland T
    Tidsskr Nor Laegeforen; 1987 Jan; 107(3):257-8, 254. PubMed ID: 3029890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.